(PharmaNewsWire.Com, June 01, 2019 ) Viral Inactivation Market by testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.
The Global Market segmented into a method, product, application, end user, and geography. The method segments included in the report are the solvent detergent method, pasteurization, and other methods. Other Viral Inactivation method includes low pH, microwave heating, irradiation, and high-energy light.
Rapidly increasing pharmaceutical and biotechnology industries and an increasing number of new biologics products launched will be the two most important growth drivers for this Viral Inactivation Market during the forecast period.
For instance, the number of new biologics products launched annually witnessed a strong upward trend. The biologics pipeline has increased by 155%, from 355 treatments. A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industry, which is an important end-user of Viral Inactivation Market products.
The pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
